AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Biotechnology

Healthcare
$5.82 +2.48%

+$0.25 today

Market cap
$286.62M
Beta
2.62
P/E (TTM)
-7.1
EPS (TTM)
-$1.28
52W Low $8.75High $17.45

Volume 0.13M

Average 0.14M

AGMB Net Income

Bottom-line profit, the starting point for calculating cash from operations.

AgomAb Therapeutics N.V. American Depositary SharesNASDAQ: AGMB

Net Income · Q4 FY2024 · quarter ended Dec 2024

Net income of -€11.73M in Q4 FY2024

Q4 FY2024 net income was -€11.73M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterDec 2024
-€11.73M— QoQ
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Net Income history

Currency unavailable · from the cash flow

No Net Income data reported for this period type.

Net Income vs competitors

How AGMB compares with its peers on the latest reported figures

AGMB Competitors
Net Income for AGMB and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALMSAlumis Inc. Common StockLTM Jun 2026$438.96M USD+92.9%+29.5%5933.5%
ACRSAclaris Therapeutics, Inc.LTM Mar 2026$69.66M USD-46.5%-9.3%832.6%
ANABAnaptysBio, Inc.LTM Mar 2026$26.79M USD-81.0%—11.5%
EQEquillium, Inc.LTM Mar 2026$19.06M USD+36.2%-28.9%—
AGMBAgomAb Therapeutics N.V. American Depositary Shares—— ———
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding AGMB) —-5.1%-9.3%832.6%

Competitors are the stored peer set for AGMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Intrinsic Alpha fair value

Locked

Current Price

$5.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.